CBL insider files Form 144 to sell 5,000 vested shares via Wells Fargo

Rhea-AI Filing Summary

CBL & Associates Properties, Inc. filed a Form 144 notifying the proposed sale of 5,000 common shares through Wells Fargo on the NYSE with an approximate aggregate market value of $155,750. The shares represent securities acquired on 02/15/2023 as an equity award under the issuer's registered 2021 Equity Incentive Plan and were noted as vested on 02/15/2025. The filing lists the approximate date of sale as 08/27/2025 and states there were 30,933,176 shares outstanding. The filer reports no related sales in the past three months and makes the standard representation that they possess no undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Routine officer/insider sale notice for vested equity, small relative to outstanding shares, likely immaterial to valuation.

The Form 144 documents a planned sale of 5,000 common shares acquired via an equity award. At an aggregate market value of $155,750, this position is small versus the 30.9 million shares outstanding, suggesting limited market impact. The filing confirms vesting and no sales in the prior three months, which is consistent with routine disposition of vested awards rather than opportunistic insider liquidation.

Corporate Governance Expert

TL;DR: Governance disclosure appears complete; signer affirms no undisclosed material information and standard Rule 144 procedures.

The notice identifies the broker, acquisition via the issuer's 2021 Equity Incentive Plan, and the intended sale date, meeting Rule 144 disclosure norms. The explicit statement that there were no related sales in the past three months and the signature attestation reduce compliance risk. This is a routine insider filing with standard representations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Wells Fargo & Company P.O. Box 66535 St. Louis MO 63166-9954	5000	155750	30933176	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	02/15/2023	5,000 shares were acquired on the date indicated through an equity award under the Issuer's registered 2021 Equity Incentive Plan.	CBL & Associates Properties, Inc.			5000	02/15/2025	Vesting of equity award under Issuer's registered 2021 Equity Incentive Plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CBL's Form 144 filed for symbol CBL disclose?

The filing discloses a proposed sale of 5,000 common shares via Wells Fargo with an aggregate market value of $155,750 and an approximate sale date of 08/27/2025.

How and when were the 5,000 CBL shares acquired?

The 5,000 shares were acquired on 02/15/2023 through an equity award under CBL's registered 2021 Equity Incentive Plan and noted as vested on 02/15/2025.

Does the Form 144 show prior sales by this person in the past three months?

No. The filing states 'Nothing to Report' for securities sold during the past three months.

Who is the broker handling the proposed sale of CBL shares?

Wells Fargo & Company (address listed as P.O. Box 66535, St. Louis, MO) is named as the broker in the filing.

How large is the proposed sale relative to CBL's outstanding shares?

The sale is 5,000 shares compared with 30,933,176 shares outstanding as reported in the filing.